[go: up one dir, main page]

NO20020668L - Ascidideminderivater og deres terapeutiske anvendelser - Google Patents

Ascidideminderivater og deres terapeutiske anvendelser

Info

Publication number
NO20020668L
NO20020668L NO20020668A NO20020668A NO20020668L NO 20020668 L NO20020668 L NO 20020668L NO 20020668 A NO20020668 A NO 20020668A NO 20020668 A NO20020668 A NO 20020668A NO 20020668 L NO20020668 L NO 20020668L
Authority
NO
Norway
Prior art keywords
ascididium
derivatives
therapeutic uses
compounds
antitumoral
Prior art date
Application number
NO20020668A
Other languages
English (en)
Norwegian (no)
Other versions
NO20020668D0 (no
Inventor
Evelyne Delfourne
Francis Darro
Jean Bastide
Robert Kiss
Armand Frydman
Original Assignee
Lafon Labor
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR9910490A external-priority patent/FR2797445B1/fr
Priority claimed from FR0006652A external-priority patent/FR2809399B1/fr
Application filed by Lafon Labor filed Critical Lafon Labor
Publication of NO20020668D0 publication Critical patent/NO20020668D0/no
Publication of NO20020668L publication Critical patent/NO20020668L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/16—Peri-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO20020668A 1999-08-13 2002-02-11 Ascidideminderivater og deres terapeutiske anvendelser NO20020668L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9910490A FR2797445B1 (fr) 1999-08-13 1999-08-13 Derives d'ascididemine et leurs applications therapeutiques
FR0006652A FR2809399B1 (fr) 2000-05-24 2000-05-24 Nouveaux derives d'ascididemine et leurs applications therapeutiques
PCT/FR2000/002312 WO2001012631A2 (fr) 1999-08-13 2000-08-11 Derives d'ascididemine et leurs applications therapeutiques

Publications (2)

Publication Number Publication Date
NO20020668D0 NO20020668D0 (no) 2002-02-11
NO20020668L true NO20020668L (no) 2002-04-15

Family

ID=26212422

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20020668A NO20020668L (no) 1999-08-13 2002-02-11 Ascidideminderivater og deres terapeutiske anvendelser

Country Status (20)

Country Link
EP (1) EP1202992B1 (es)
JP (1) JP2003507381A (es)
CN (1) CN1195754C (es)
AT (1) ATE276256T1 (es)
AU (1) AU779932B2 (es)
BR (1) BR0013249A (es)
CA (1) CA2393965A1 (es)
CZ (1) CZ2002528A3 (es)
DE (1) DE60013849T2 (es)
DK (1) DK1202992T3 (es)
ES (1) ES2228602T3 (es)
HU (1) HUP0202767A3 (es)
IL (1) IL147900A0 (es)
MX (1) MXPA02001512A (es)
NO (1) NO20020668L (es)
NZ (1) NZ516896A (es)
PL (1) PL353453A1 (es)
PT (1) PT1202992E (es)
SK (1) SK1662002A3 (es)
WO (1) WO2001012631A2 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3548486B1 (de) * 2016-12-05 2021-10-27 Merck Patent GmbH Materialien für organische elektrolumineszenzvorrichtungen

Also Published As

Publication number Publication date
PL353453A1 (en) 2003-11-17
BR0013249A (pt) 2002-04-16
NZ516896A (en) 2004-02-27
CA2393965A1 (fr) 2001-02-22
NO20020668D0 (no) 2002-02-11
ATE276256T1 (de) 2004-10-15
ES2228602T3 (es) 2005-04-16
JP2003507381A (ja) 2003-02-25
SK1662002A3 (en) 2002-09-10
DE60013849D1 (de) 2004-10-21
CN1195754C (zh) 2005-04-06
PT1202992E (pt) 2004-12-31
EP1202992B1 (fr) 2004-09-15
HUP0202767A3 (en) 2003-12-29
CN1373762A (zh) 2002-10-09
DK1202992T3 (da) 2005-01-24
AU779932B2 (en) 2005-02-17
WO2001012631A2 (fr) 2001-02-22
WO2001012631A3 (fr) 2001-07-19
IL147900A0 (en) 2002-08-14
HUP0202767A2 (hu) 2003-01-28
CZ2002528A3 (cs) 2002-05-15
DE60013849T2 (de) 2005-02-03
MXPA02001512A (es) 2002-07-02
EP1202992A2 (fr) 2002-05-08
AU7012400A (en) 2001-03-13

Similar Documents

Publication Publication Date Title
GEP20063799B (en) Tropane derivatives useful in therapy
AP9801169A0 (en) N-hydroxy-B-sulfonyl propionamide derivatives.
GEP20032896B (en) 4-Aminothiazole Derivatives, Containing Them Pharmaceutical Compositions Inhibiting Cyclin-Dependent Kinases and Methods for Treatment
SE0102438D0 (sv) New compounds
GB0114286D0 (en) Nucleoside Derivatives
GEP20053600B (en) 3-(4-Amidopyrrol-2-Ylmethlidene)-2- Indolinone Derivatives as Protein Kinase Inhibitors
AP2002002578A0 (en) Dihydro-1,3,5-triazine amine derivatives and their therapeutic uses.
TR200402656T4 (tr) Antikanser ajanları olarak faydalı tiyofen türevleri
GEP20063831B (en) Substituted bicyclic derivatives for treatment of abnormal cell growth
DE69931925D1 (de) 2-chinolonen enthaltende arzneimittel
AP9801378A0 (en) 9-amino-3- keto erythromycin derivatives.
DE60003863D1 (de) Dioxocyclopentylhydroxamsäure
GEP20063751B (en) 2-Acyl Indol Derivatives and Their Use as Anti-Tumour Agents
SE9900961D0 (sv) Novel compounds
MY140630A (en) Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
PT992509E (pt) Novos derivados macrolidos
TW200504029A (en) Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
SE0003476D0 (sv) Compounds
TW200504030A (en) Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
AP9801377A0 (en) Tricyclic erythromycin derivatives.
GEP20043225B (en) 1-Trifluoromethyl-4-Hydroxy-7- Piperidinyl-Aminomethylchroman Derivatives
PT1292303E (pt) Formulacao farmaceutica estavel compreendendo modificacao de torsemida ii
NO20020669L (no) Fenantrolin-7-on-derivater og deres terapeutiske anvendelser
NO20020668D0 (no) Ascidideminderivater og deres terapeutiske anvendelser
YU46302A (sh) Supstituisani piroli

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application